Bavarian Nordic enters trials with prostate cancer vaccine
Jan Rodriuez wrote an interesting post today on
Here’s a quick excerpt
Bavarian Nordic enters trials with prostate cancer vaccine June 4th, 2008 Posted in prostate cancer prevention | No Comments » Bavarian Nordic’s subsidiary, BN ImmunoTherapeutics has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer. A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the US. Secondary objectives of the trial include examining
Read the rest of this great post here